Cigna modified MM 0543 covering orthotic devices and shoes, effective November 15, 2025. Here's what billing teams need to do.
Cigna Healthcare updated its orthotic devices and shoes coverage policy under MM 0543, with changes affecting a broad range of HCPCS codes — from cranial remolding orthoses (S1040) to powered upper extremity devices (L8701, L8702) to protective helmets (A8000–A8004). This policy governs medical necessity criteria for static and dynamic orthoses, custom foot orthoses, knee braces, spinal devices, and therapeutic shoes. If your practice or DME supplier bills Cigna for any of these categories, your charge capture and documentation protocols need to reflect the updated criteria before the November 15, 2025 effective date.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Orthotic Devices and Shoes — MM 0543 |
| Policy Code | MM 0543 |
| Change Type | Modified |
| Effective Date | November 15, 2025 |
| Impact Level | High |
| Specialties Affected | Orthotics & Prosthetics, Physical Medicine & Rehabilitation, Pediatrics, Neurology, Podiatry, DME Suppliers |
| Key Action | Audit active Cigna claims for orthotic devices against updated medical necessity criteria — especially for knee braces (L1844, L1846), powered devices (L8701, L8702, K1007), and cranial orthoses (S1040) — before November 15, 2025 |
Cigna Orthotic Devices Coverage Criteria and Medical Necessity Requirements 2025
The Cigna orthotic devices coverage policy under MM 0543 covers a wide range of devices — but the coverage is not automatic. Each category carries its own medical necessity criteria, and Cigna distinguishes sharply between what is medically necessary, what is experimental, and what is simply not covered.
The general framework applies across all device types: the orthosis must support, align, prevent, or correct a deformity, or facilitate body motion for optimal function. Static orthoses — rigid devices used for weakened or paralyzed body parts — and dynamic orthoses both fall under this framework. Myoelectric orthotic devices, which use neurologic sensors, microprocessors, and electric motors, face additional scrutiny.
Cranial Orthoses (S1040)
S1040 — cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated — is considered medically necessary when the applicable criteria are met. This is a pediatric-specific code for positional or deformational plagiocephaly. Documentation must establish medical necessity as required under MM 0543 criteria. If you bill S1040, verify that clinical notes support the diagnosis and meet Cigna's stated requirements before ordering the orthosis.
Knee Braces (L1844, L1846)
L1844 (knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint) and L1846 (knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint) are both considered medically necessary when applicable criteria are met. The policy also references ambulatory status in the context of the experimental/investigational group row for L1844 and L1845. Review the full MM 0543 policy text to confirm how ambulatory status applies to your specific patient population before billing.
Powered Upper Extremity Devices (L8701, L8702)
L8701 (powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright) and L8702 (powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright) are considered medically necessary under the applicable criteria. These are high-cost items, and Cigna's medical necessity requirements for powered devices are strict. Verify coverage requirements with Cigna directly before submitting claims for these codes.
Therapeutic Shoes (A5503–A5507)
The diabetic shoe and shoe modification codes — A5503 through A5507, covering modifications such as rigid rocker bottoms, roller bottoms, wedges, metatarsal bars, and offset or flared heels — may be considered medically necessary and are often covered when used for appropriate diabetic foot conditions. The ICD-10 diagnosis codes matter enormously here. Cigna's code list covers the full range of diabetes mellitus types (E08–E13), including neurological and circulatory complications. Match the shoe modification codes to a supported diabetes diagnosis — and document the clinical basis thoroughly.
Cigna Orthotic Devices Exclusions and Non-Covered Indications
This is where the policy gets important for claim denial prevention. Cigna draws clear lines on several device categories.
Protective Helmets: Not Covered
A8000 (soft, prefabricated), A8001 (hard, prefabricated), A8002 (soft, custom fabricated), A8003 (hard, custom fabricated), and A8004 (soft interface, replacement only) are all classified as safety devices — not medical devices — and are not covered or reimbursable under this policy. Don't bill these to Cigna expecting payment. If a patient needs a protective helmet, have the financial conversation upfront.
Experimental, Investigational, or Unproven Devices
Several codes fall into Cigna's experimental/investigational/unproven category. These will generate denials regardless of documentation:
| # | Excluded Procedure |
|---|---|
| 1 | K1007 — bilateral hip, knee, ankle, foot device, powered, includes pelvic component, single or double upright. This powered exoskeleton-type device is experimental under MM 0543. |
| 2 | L2006 — knee ankle foot device, any material, single or double upright, swing and/or stance phase microprocessor. The microprocessor-controlled KAFO falls into experimental status. |
| 3 | L3161 — foot, adductus positioning device, adjustable. Experimental designation. |
| 4 | L1844/L1845 used outside applicable criteria — the policy references L1844 and L1845 together in the experimental/investigational group row, tied to ambulatory status and applicable criteria. Review the full MM 0543 policy text to understand exactly when these codes cross into experimental territory. |
The real issue here is the microprocessor-controlled device category. K1007 and L2006 both involve electronic/microprocessor components — exactly the category Cigna flags as experimental. If you're billing powered orthotic devices to Cigna, verify the specific code against the MM 0543 experimental list before you submit.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Cranial remolding for pediatric positional plagiocephaly | Covered | S1040 | Medical necessity criteria must be met; custom fabricated only |
| Knee bracing — medically necessary when applicable criteria met | Covered | L1844, L1846 | Review full MM 0543 criteria; ambulatory status referenced in experimental group context |
| Powered upper extremity ROM assist devices | Covered | L8701, L8702 | Applicable criteria required; verify coverage requirements with Cigna directly |
| Diabetic shoe modifications (covered diabetes DX) | Covered | A5503–A5507 | Must pair with E08–E13 ICD-10 codes; document clinical need |
| Protective helmets (any type) | Not Covered | A8000–A8004 | Classified as safety devices, not medical devices |
| Powered bilateral hip/knee/ankle/foot device | Experimental | K1007 | Considered investigational regardless of indication |
| Microprocessor-controlled KAFO | Experimental | L2006 | Swing/stance phase microprocessor devices = experimental |
| Adductus positioning device, adjustable | Experimental | L3161 | No covered indication under current policy |
| L1844/L1845 outside applicable criteria | Experimental | L1844, L1845 | Referenced together in experimental group row; review full policy for criteria boundaries |
Cigna Orthotic Devices Billing Guidelines and Action Items 2025
The effective date of November 15, 2025 is your deadline. Here are the specific steps your billing team needs to take now.
| # | Action Item |
|---|---|
| 1 | Audit your Cigna charge master for K1007 and L2006 before November 15, 2025. Both codes are experimental under MM 0543. If either appears in your active charge capture for Cigna patients, flag them. Submitting these codes after the effective date means denials you'll have to write off or appeal. |
| 2 | Remove A8000–A8004 from your Cigna billing workflow. These protective helmet codes are not covered — not experimental, just not reimbursable. If you've been billing these, pull a 90-day remittance audit to see if any got through and correct your workflow going forward. |
| 3 | Verify coverage requirements for L8701 and L8702 with Cigna directly. Powered upper extremity orthoses carry the highest denial risk in this policy. Confirm requirements through your provider rep or the Cigna portal before submitting claims. |
| 4 | Verify documentation for all knee brace claims (L1844, L1846) against the full MM 0543 criteria. The policy references ambulatory status in the experimental group context for L1844 and L1845. Pull the complete policy text to confirm what documentation your ordering providers need to include. If you're unsure how the criteria apply to your patient mix, talk to your compliance officer before the effective date. |
| 5 | Pair diabetic shoe modification codes (A5503–A5507) with the correct ICD-10 range. The E08–E13 diabetes code families are the supported diagnoses. Codes with neurological complications (E08.40–, E10.40–, E11.40–) and circulatory complications (E08.51–, E10.51–, E11.51–) are specifically listed. Match the shoe modification to the patient's documented complication — don't use E11.9 as a catch-all if the chart supports a more specific code. |
| 6 | Train your billing team on the static vs. dynamic vs. myoelectric distinction. Cigna's MM 0543 applies different standards to each device class. Myoelectric devices — the ones with neurologic sensors, microprocessors, and electric motors — face the strictest scrutiny. If you're not sure how a device is classified, pull the product documentation before billing. |
If your mix includes a high volume of powered orthotic devices or pediatric cranial orthoses, loop in your compliance officer before November 15, 2025. The experimental designations in this policy have real financial exposure.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Orthotic Devices Under MM 0543
Medically Necessary HCPCS Codes (When Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| S1040 | HCPCS | Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s) |
| L1844 | HCPCS | Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric) |
| L1846 | HCPCS | Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric) |
| L8701 | HCPCS | Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright |
| L8702 | HCPCS | Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright |
| A5503–A5507 | HCPCS | Diabetic shoe modifications — rigid rocker bottoms, roller bottoms, wedges, metatarsal bars, offset heels, flared heels (group; individual descriptions not assigned per code in source policy) |
Experimental / Investigational / Unproven HCPCS Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| K1007 | HCPCS | Bilateral hip, knee, ankle, foot device, powered, includes pelvic component, single or double upright | Considered experimental/investigational/unproven |
| L2006 | HCPCS | Knee ankle foot device, any material, single or double upright, swing and/or stance phase microprocessor | Considered experimental/investigational/unproven |
| L3161 | HCPCS | Foot, adductus positioning device, adjustable | Considered experimental/investigational/unproven |
| L1844, L1845 | HCPCS | Knee orthosis codes referenced together in experimental group row | Considered experimental/investigational/unproven outside applicable criteria; review full policy for criteria boundaries |
Not Covered HCPCS Codes (Protective Helmets — Safety Devices)
| Code | Type | Description | Reason |
|---|---|---|---|
| A8000 | HCPCS | Helmet, protective, soft, prefabricated, includes all components and accessories | Safety device — not covered |
| A8001 | HCPCS | Helmet, protective, hard, prefabricated, includes all components and accessories | Safety device — not covered |
| A8002 | HCPCS | Helmet, protective, soft, custom fabricated, includes all components and accessories | Safety device — not covered |
| A8003 | HCPCS | Helmet, protective, hard, custom fabricated, includes all components and accessories | Safety device — not covered |
| A8004 | HCPCS | Soft interface for helmet, replacement only | Safety device — not covered |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| A52.15 | Late syphilitic neuropathy |
| E08.00– | Diabetes mellitus due to underlying condition |
| E08.40– | Diabetes mellitus due to underlying condition with neurological complications |
| E08.49 | Diabetes mellitus due to underlying condition with neurological complications (range end) |
| E08.51– | Diabetes mellitus due to underlying condition with circulatory complications |
| E08.59 | Diabetes mellitus due to underlying condition with circulatory complications (range end) |
| E08.610 | Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy |
| E08.9 | Diabetes mellitus due to underlying condition, unspecified |
| E09.00– | Drug or chemical induced diabetes mellitus |
| E09.40– | Drug or chemical induced diabetes mellitus with neurological complications |
| E09.49 | Drug or chemical induced diabetes mellitus with neurological complications (range end) |
| E09.51– | Drug or chemical induced diabetes mellitus with circulatory complications |
| E09.59 | Drug or chemical induced diabetes mellitus with circulatory complications (range end) |
| E09.610 | Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy |
| E09.65 | Drug or chemical induced diabetes mellitus due to underlying condition with hyperglycemia |
| E09.9 | Drug or chemical induced diabetes mellitus, unspecified |
| E10.10– | Type 1 diabetes mellitus |
| E10.40– | Type 1 diabetes mellitus with neurological complications |
| E10.49 | Type 1 diabetes mellitus with neurological complications (range end) |
| E10.51– | Type 1 diabetes mellitus with circulatory complications |
| E10.59 | Type 1 diabetes mellitus with circulatory complications (range end) |
| E10.610 | Type 1 diabetes mellitus with diabetic neuropathic arthropathy |
| E10.9 | Type 1 diabetes mellitus, unspecified |
| E11.00– | Type 2 diabetes mellitus |
| E11.40– | Type 2 diabetes mellitus with neurological complications |
| E11.49 | Type 2 diabetes mellitus with neurological complications (range end) |
| E11.51– | Type 2 diabetes mellitus with circulatory complications |
| E11.59 | Type 2 diabetes mellitus with circulatory complications (range end) |
| E11.610 | Type 2 diabetes mellitus with diabetic neuropathic arthropathy |
| E11.A | Type 2 diabetes mellitus (additional manifestation) |
| E13.00– | Other specified diabetes mellitus |
| E13.40– | Other specified diabetes mellitus with neurological complications |
| E13.49 | Other specified diabetes mellitus with neurological complications (range end) |
| E13.51– | Other specified diabetes mellitus with circulatory complications |
| E13.59 | Other specified diabetes mellitus with circulatory complications (range end) |
| E13.610 | Other specified diabetes mellitus with diabetic neuropathic arthropathy |
| E13.9 | Other specified diabetes mellitus, unspecified |
| G11.4 | Hereditary spastic paraplegia |
| G12.0–G12.9 | Spinal muscular atrophy and related syndromes |
| G13.0 | Paraneoplastic neuromyopathy and neuropathy |
| G13.1 | Other systemic atrophy primarily affecting central nervous system in neoplastic disease |
| G24.09 | Other drug induced dystonia |
| G24.2 | Idiopathic nonfamilial dystonia |
| G24.8 | Other dystonia |
| G57.01–G57.03 | Lesion of sciatic nerve |
| G57.11–G57.13 | Meralgia paresthetica |
| G57.21–G57.23 | Lesion of femoral nerve |
| G57.31–G57.33 | Lesion of lateral popliteal nerve |
| G57.40–G57.43 | Lesion of medial popliteal nerve |
| G57.51–G57.53 | Tarsal tunnel syndrome |
| G57.61–G57.63 | Lesion of plantar nerve |
| G57.71–G57.73 | Causalgia of lower limb |
| G57.81–G57.83 | Other specified mononeuropathies of lower limb |
| G57.91–G57.93 | Unspecified mononeuropathy of lower limb |
| G58.8 | Other specified mononeuropathies |
The full ICD-10 list under MM 0543 contains 349 codes. The table above reflects the codes provided in the policy data. Verify the complete list at the Cigna MM 0543 source document.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.